X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - Times of India - Life & Style - 13/12/2024 17:13

A simple pill can soon cure diabetes: Scientists

Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.

Articles similaires

Sorry! Image not available at this time

PFAS exposure linked to gestational diabetes and insulin problems

news.medical.net - 14/Jan 16:51

Exposure to per- and polyfluoroalkyl substances (PFAS), a class of highly persistent environmental chemicals commonly referred to as "forever...

Sorry! Image not available at this time

A hydration guide for people on GLP-1s

wn.com - 14/Jan 03:25

Mumumutelu // Shutterstock Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are used to treat obesity, Type 2 diabetes, and more. These...

Sorry! Image not available at this time

A hydration guide for people on GLP-1s

wn.com - 14/Jan 03:25

Mumumutelu // Shutterstock Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are used to treat obesity, Type 2 diabetes, and more. These...

Sorry! Image not available at this time

Dr Reddy's set to start selling generic Ozempic in India at potentially half price

hindustantimes.com - 22/Jan 03:50

The prices of Ozempic in India can potentially halve to ₹3,600 after Dr. Reddy's and its ilk start producing the generic version of semaglutide,...

Sorry! Image not available at this time

Dr Reddy's set to start selling generic Ozempic in India at potentially half price

hindustantimes.com - 22/Jan 03:50

The prices of Ozempic in India can potentially halve to ₹3,600 after Dr. Reddy's and its ilk start producing the generic version of semaglutide,...

Sorry! Image not available at this time

ASCO GI: GLP-1 Receptor Agonist Use Linked to Reduced CRC Incidence

drugs.com - 12/Jan 15:01

MONDAY, Jan. 12, 2026 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC)...

Sorry! Image not available at this time

ASCO GI: GLP-1 Receptor Agonist Use Linked to Reduced CRC Incidence

drugs.com - 12/Jan 15:01

MONDAY, Jan. 12, 2026 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC)...

Sorry! Image not available at this time

Pharmac seeking clinical advice on funding Wegovy weight loss medication

rnz.co.nz - 17/Jan 17:40

Pharmac received two applications to fund Wegovy or semaglutide - a GLP-1 receptor agonist for weight loss.

Sorry! Image not available at this time

Pharmac seeking clinical advice on funding Wegovy weight loss medication

rnz.co.nz - 17/Jan 17:40

Pharmac received two applications to fund Wegovy or semaglutide - a GLP-1 receptor agonist for weight loss.

Sorry! Image not available at this time

Funding Wegovy will save taxpayer money in long run - specialist

rnz.co.nz - 18/Jan 20:38

Pharmac has received two applications to fund Wegovy or semaglutide - a GLP-1 receptor agonist for weight loss.

Les derniers communiqués